Claude

The People Running Everest Industries

Governance grade: B-. The Sekhsaria family (Ambuja Cement founders) hold majority control at 50.2% and have a credible industrial track record, but the company is navigating a leadership transition during a period of financial distress, with a CRISIL credit downgrade in November 2025 and negative ROE. The board is well-constituted on paper, but management execution has been disappointing.

The People Running This Company

Rajesh Joshi served as MD & CEO from March 2024 through September 12, 2025 – a tenure of barely 18 months. His short stint coincided with a difficult period: the stock fell over 55% from its 52-week high of 750 to 285, CRISIL downgraded the credit rating, and ROE turned negative. Before Everest, Joshi held senior roles at Asian Paints, Pidilite, and Bharti Airtel.

Hemant Khurana was appointed as the replacement MD & CEO effective September 13, 2025, on a three-year term through September 2028. He brings deep building-materials expertise from nearly 24 years at Saint-Gobain, where he was MD of Weber India and founded the MyHome business. His hiring signals the promoters' intent to bring a domain specialist after the generalist Joshi era underperformed.

The real power resides with the Narotam Sekhsaria Family Office (NSFO), which controls 50.2% through promoter entities. Padmini Sekhsaria, daughter of Narotam Sekhsaria (the founder of Ambuja Cements who built it into one of India's most efficient cement companies before divesting to Holcim in 2006), actively leads NSFO's global operations. NSFO has AUM exceeding $1 billion and operates across India, UK, and UAE.

Anant Talaulicar brings heavyweight corporate governance credentials as Chairman. He ran Cummins India for 13 years, was on Cummins Inc.'s global leadership team, and now sits on seven boards including KPIT Technologies and Jakson Group.

What They Get Paid

Hemant Khurana's package totals 3.00 Cr fixed annually (Base: 1.05 Cr, Allowances: 1.77 Cr, Retirals: 17.65 Lakhs), with a one-time 50 Lakh signing bonus and 30,000 ESOPs in FY2026. His variable pay is tied to two hard metrics with escalating targets:

By FY2028, the board expects 15% revenue growth and 15% ROCE – a dramatic improvement from current negative returns. Variable pay at 75% of target kicks in at 7% revenue growth / 4% ROCE, while 120% pays out at 11% growth / 6% ROCE for FY2026. This is a well-designed structure that forces the MD to deliver both growth and capital efficiency simultaneously.

Anant Talaulicar was approved for commission up to 2.00 Cr for FY2026, subject to a 4% net profits cap. The board explicitly noted this exceeds 50% of total NED compensation, requiring shareholder approval under SEBI LODR. For a company with 531 Cr market cap, this is on the higher side, though Talaulicar's stature and the turnaround context arguably justify it.

Rajesh Joshi was granted 48,717 ESOPs in FY2022 as part of the ESOS-2021 scheme. His total compensation during his short tenure was not separately disclosed in the available data.

Are They Aligned?

Ownership and Control: The Sekhsaria promoter group holds 50.22%, giving them majority control. This is a family-office holding, not a traded stake – NSFO's interests are long-term. The family's wealth derives primarily from the Ambuja Cement exit (divested to Holcim in 2006), making Everest a relatively small part of their portfolio but one where they exercise active governance through Padmini Sekhsaria's vice-chairperson role.

Insider Buying / Selling: No significant insider trading activity was found in the data. The absence of insider buying during a 55%+ stock price decline from 750 to 285 is not encouraging. If management and promoters were confident in a turnaround, open-market purchases would send a clear signal.

Dilution / ESOPs: The ESOS-2021 scheme has granted modest quantities – 48,717 to Joshi, 30,000 to Khurana. With approximately 1.58 Cr shares outstanding (paid-up capital of 15.79 Cr at face value of 10), annual ESOP dilution is well under 1%, which is shareholder-friendly.

Related-Party Behavior: The NSFO entities (Madhurima International, Radha Madhav Industries, Falak Investment) are the promoter holding vehicles. No evidence of problematic related-party transactions was found – no excessive management fees, intercompany loans, or rent payments flowing to promoter entities. The promoter structure is transparent and publicly documented on the NSFO website.

Capital Allocation: The company pays a modest dividend (0.75% yield) despite trading below book value (P/B 0.92). With negative ROE and a credit downgrade, capital allocation is constrained. The board's decision to invest in a leadership upgrade rather than cutting costs signals a growth-oriented approach.

Score of 6/10: The 50%+ promoter stake provides baseline alignment, and the Sekhsaria family has a credible long-term track record (Ambuja Cements was a world-class company under their stewardship). However, the absence of visible insider buying during significant price weakness, combined with management churn, limits the score.

Board Quality

Strengths: The 57% independence ratio meets SEBI requirements. The independents bring genuinely diverse expertise. Rajendra Chitale (CA + LLB, managing partner of Chitale & Associates) adds financial and audit capability. Alok Nanda, as former GE South Asia CTO, brings technology and R&D perspective. Ashok Kumar Barat's extensive CEO experience (Forbes & Co, HUL, RPG, Pepsi) provides operational challenge capability. Bijal Ajinkya (Khaitan & Co partner, first Indian-qualified lawyer admitted to the American College of Trust and Estate Practitioners) adds legal and international structuring expertise.

Concerns: Rajendra Chitale previously served on the Ambuja Cements board (also a Sekhsaria promoter company) and has been on the Everest board since 2018, raising a question about his true independence from the promoter family's influence. Two directors (Barat and Ajinkya) were appointed as recently as March 2024, so they are still building institutional knowledge.

Missing Expertise: The board lacks an independent director with deep fibre-cement or building-products manufacturing experience. The new MD (Khurana) fills this gap operationally, but independent challenge on product strategy and manufacturing efficiency would be valuable.

The Verdict

Strongest Positives: The Sekhsaria family's track record with Ambuja Cements – building it into India's most efficient cement company and making a disciplined exit to Holcim – provides genuine confidence in their long-term business judgment. The hire of Hemant Khurana as MD, with his 24-year domain pedigree from Saint-Gobain Weber, signals serious intent to fix the business. His compensation structure, tied to revenue growth and ROCE with escalating targets, is well-designed. Board independence at 57% with capable independent directors is solid.

Real Concerns: Management churn is the biggest governance risk. Rajesh Joshi lasted only 18 months. This pattern suggests either the promoters set unrealistic expectations, they micromanage, or the business is structurally harder to turn around than expected. The CRISIL credit downgrade from A to A- with negative outlook (November 2025) adds execution risk during this leadership transition. The stock's 55%+ decline and negative ROE (-5.6%) mean that governance quality is being tested under real stress.

Upgrade Catalyst: Sustained improvement in ROCE toward Khurana's targets (5% in FY2026, 10% in FY2027), combined with Khurana completing at least 18+ months without departure, would justify upgrading to B+.

Downgrade Trigger: Another MD departure within two years, further credit downgrades, or evidence of promoter entities extracting value during financial stress would push this to C+ territory.